pembrolizumab
merck
['pembro', 'keynote-826']
keynote-826 update confirms survival benefit with addition of pembrolizumab to first-line chemotherapy in cervical cancer #asco23 
Oncology CNS/#EvidenceBasedPractice/#PallCare/ @Oncoalert /Health Policy Advocate/.@DukeU_NrsgSchl alum  ASCO FCOI: https://t.co/LdXn1zfEGv